Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • skannan4
    Junior Member
    • Sep 2017
    • 5

    #1

    Handling pseudogenes in RNA-seq

    I recently performed an RNA-seq experiment that was mapped using STAR through a package called zUMIs. Typically, our reads are 66 bp (and in the past our experiments have been mapped to the human genome) but this time our data ended up being 50 bp reads to the mouse genome. Our final counts dataset seems to be dominated by pseudogenes; close to 25% of the UMIs are linked to pseudogenes.

    Of course, while pseudogenes can be transcribed, in our case it seems more likely that we have had an issue from the mapping front (I'm guessing due to the shorter read length). From our biological context, we certainly don't expect a massive number of transcribed pseudogenes. My question is - is there any way to coalesce the counts between genes and their corresponding pseudogenes (without remapping)? And if there isn't a good way to handle this, what STAR settings should we try adjusting to map to further promote mapping to canonical genes over pseudogenes?

    Thanks!

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...